Review



human genome u133 plus2.0 microarray  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Thermo Fisher human genome u133 plus2.0 microarray
    Content of <t> Plus2.0 </t> array and Colorectal DSA
    Human Genome U133 Plus2.0 Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human genome u133 plus2.0 microarray/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    human genome u133 plus2.0 microarray - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "The Colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information"

    Article Title: The Colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information

    Journal: BMC Cancer

    doi: 10.1186/1471-2407-10-687

    Content of Plus2.0 array and Colorectal DSA
    Figure Legend Snippet: Content of Plus2.0 array and Colorectal DSA

    Techniques Used:

    Complete probeset analysis . Results from the analysis of the complete content of the Plus2.0 array and the Colorectal DSA. A. Graph showing the number of probesets consistently detected (P or M) across all three replicates of parental untreated, parental 5-FU treated, 5-FU-resistant untreated and 5-FU-resistant 5-FU treated. B. Graph displaying the number of probesets detected, differentially expressed (at 1.3-fold) and passing t-test filter (p < 0.05) in the parental and 5-FU-resistant cells following 5-FU treatment.
    Figure Legend Snippet: Complete probeset analysis . Results from the analysis of the complete content of the Plus2.0 array and the Colorectal DSA. A. Graph showing the number of probesets consistently detected (P or M) across all three replicates of parental untreated, parental 5-FU treated, 5-FU-resistant untreated and 5-FU-resistant 5-FU treated. B. Graph displaying the number of probesets detected, differentially expressed (at 1.3-fold) and passing t-test filter (p < 0.05) in the parental and 5-FU-resistant cells following 5-FU treatment.

    Techniques Used:

    Pathway analysis from Plus2.0 array
    Figure Legend Snippet: Pathway analysis from Plus2.0 array

    Techniques Used:



    Similar Products

    human genome u133 plus2.0 microarray  (Thermo Fisher)
    90
    Thermo Fisher human genome u133 plus2.0 microarray
    Content of <t> Plus2.0 </t> array and Colorectal DSA
    Human Genome U133 Plus2.0 Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human genome u133 plus2.0 microarray/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    human genome u133 plus2.0 microarray - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    human genome u133 (hg u133) plus2.0 microarray platform  (Thermo Fisher)
    90
    Thermo Fisher human genome u133 (hg u133) plus2.0 microarray platform
    Computational pipeline for re-annotating the probes of the Affymetrix Human Genome <t>U133</t> <t>plus2.0</t> array
    Human Genome U133 (Hg U133) Plus2.0 Microarray Platform, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human genome u133 (hg u133) plus2.0 microarray platform/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    human genome u133 (hg u133) plus2.0 microarray platform - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Content of Plus2.0 array and Colorectal DSA

    Journal: BMC Cancer

    Article Title: The Colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information

    doi: 10.1186/1471-2407-10-687

    Figure Lengend Snippet: Content of Plus2.0 array and Colorectal DSA

    Article Snippet: To assess the benefit of the Almac Diagnostics Colorectal Cancer Disease-Specific Array (further referred as "Colorectal DSA") we compared it directly to the Affymetrix Human Genome U133 Plus2.0 microarray (further referred as "Plus2.0 array").

    Techniques:

    Complete probeset analysis . Results from the analysis of the complete content of the Plus2.0 array and the Colorectal DSA. A. Graph showing the number of probesets consistently detected (P or M) across all three replicates of parental untreated, parental 5-FU treated, 5-FU-resistant untreated and 5-FU-resistant 5-FU treated. B. Graph displaying the number of probesets detected, differentially expressed (at 1.3-fold) and passing t-test filter (p < 0.05) in the parental and 5-FU-resistant cells following 5-FU treatment.

    Journal: BMC Cancer

    Article Title: The Colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information

    doi: 10.1186/1471-2407-10-687

    Figure Lengend Snippet: Complete probeset analysis . Results from the analysis of the complete content of the Plus2.0 array and the Colorectal DSA. A. Graph showing the number of probesets consistently detected (P or M) across all three replicates of parental untreated, parental 5-FU treated, 5-FU-resistant untreated and 5-FU-resistant 5-FU treated. B. Graph displaying the number of probesets detected, differentially expressed (at 1.3-fold) and passing t-test filter (p < 0.05) in the parental and 5-FU-resistant cells following 5-FU treatment.

    Article Snippet: To assess the benefit of the Almac Diagnostics Colorectal Cancer Disease-Specific Array (further referred as "Colorectal DSA") we compared it directly to the Affymetrix Human Genome U133 Plus2.0 microarray (further referred as "Plus2.0 array").

    Techniques:

    Pathway analysis from Plus2.0 array

    Journal: BMC Cancer

    Article Title: The Colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information

    doi: 10.1186/1471-2407-10-687

    Figure Lengend Snippet: Pathway analysis from Plus2.0 array

    Article Snippet: To assess the benefit of the Almac Diagnostics Colorectal Cancer Disease-Specific Array (further referred as "Colorectal DSA") we compared it directly to the Affymetrix Human Genome U133 Plus2.0 microarray (further referred as "Plus2.0 array").

    Techniques:

    Computational pipeline for re-annotating the probes of the Affymetrix Human Genome U133 plus2.0 array

    Journal: Oncotarget

    Article Title: Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma

    doi: 10.18632/oncotarget.9880

    Figure Lengend Snippet: Computational pipeline for re-annotating the probes of the Affymetrix Human Genome U133 plus2.0 array

    Article Snippet: The GSE62232 dataset met our criteria and the Affymetrix human genome U133 (HG U133) Plus2.0 microarray platform was used in this study.

    Techniques: